BioXion is an AI-powered intelligence platform covering CMC development, CDMO oversight, analytical operations, quality management, regulatory affairs, and supply chain — built for biopharma teams, hosted in Switzerland.

WHY BIOXION EXISTS

Biopharma teams are managing complexity with tools that weren't built for it

Spreadsheets, emails, and disconnected systems can't keep up with the demands of modern drug development. CDMO deliverables, method lifecycles, regulatory timelines, quality events, and supply dependencies are tracked in silos — or not tracked at all. BioXion connects your data and surfaces intelligence when decisions need to be made.

THE PLATFORM

Seven intelligence modules. One connected ecosystem.

Seven intelligence modules. One connected ecosystem.

BUILT FOR THE PEOPLE WHO RUN BIOPHARMA PROGRAMS

The right intelligence for the right team

  • CMC Directors — Program oversight, milestone tracking, gap analysis

  • Analytical Development Leads — Method lifecycle, validation status, transfer readiness

  • CDMO / External Manufacturing — Vendor management, tech transfer, deliverable tracking

  • Regulatory Affairs — Submission readiness, dossier alignment, intelligence monitoring

  • Quality & Supply Chain — Event management, deviation trends, supply risk visibility

Swiss Data Residency · Claude API/Azure OpenAI Switzerland North · Non-GxP Intelligence Layer · Entity Masking · EU AI Act Aligned

What you need to know

FAQ Decoration Image

Is BioXion a GxP validated system?

No — by design. BioXion is a non-GxP intelligence layer. It does not replace your validated QMS, LIMS, or ELN. It reads, connects, and interprets data from your existing ecosystem.

Where is my data stored?

All data is hosted in Switzerland via Infomaniak/Jelastic, with AI processing through Claude API/Azure OpenAI Switzerland North. Data never leaves Swiss/EU jurisdiction.

How do I get access?

Early access is by application. Submit your email below and we'll reach out when your spot is ready.

Schedule a call

We are onboarding a selected group of early access partners to shape the product. Let's discuss your development challenges and explore how BioXion and Helvetia Tech Solutions can support your program.

We are onboarding a selected group of early access partners to shape the product. Let's discuss your development challenges and explore how BioXion and Helvetia Tech Solutions can support your program.